DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/73vqkn/typhoid_fever) has announced the addition of the "Typhoid Fever - Pipeline Review, H2 2013" report to their offering.
'Typhoid Fever - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Typhoid Fever, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Typhoid Fever.
- A snapshot of the global therapeutic scenario for Typhoid Fever.
- A review of the Typhoid Fever products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Typhoid Fever pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Companies Involved in Typhoid Fever Therapeutics Development
- Nanotherapeutics, Inc.
- Novartis AG
- Bharat Biotech International Limited
- Shantha Biotechnics Limited
- Vi-CRM197 Glycoconjugated Vaccine
- Typhoid TT Vaccine
- Vi-CRM197 PCMV
- Vi-Diptheria Toxoid Conjugate Typhoid Vaccine
- Bivalent Enteric Fever Conjugate Vaccine
- Vi-PspA Vaccine
- OmpC-Vi Conjugate Vaccine
For more information visit http://www.researchandmarkets.com/research/73vqkn/typhoid_fever